1887

Abstract

Upon antiretroviral therapy (ART) human immunodeficiency virus (HIV)/human T-cell lymphotropic virus type 1 (HTLV-1) co-infected individuals frequently develop neurological disorders through hitherto unknown mechanisms. Here, we show that effective anti-HIV ART increases HTLV-1 proviral load through a polyclonal integration pattern of HTLV-1 in both CD4 and CD8 T-cell subsets that is reminiscent of that typically associated with HTLV-1-related inflammatory conditions. These data indicate that preventing ART-triggered clonal expansion of HTLV-1-infected cells in co-infected individuals deserves investigation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.048348-0
2013-04-01
2019-12-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/4/753.html?itemId=/content/journal/jgv/10.1099/vir.0.048348-0&mimeType=html&fmt=ahah

References

  1. Beilke M. A., Japa S., Vinson D. G.. ( 1998;). HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection. . J Acquir Immune Defic Syndr Hum Retrovirol 17:, 391–397. [CrossRef][PubMed]
    [Google Scholar]
  2. Beilke M. A., Japa S., Moeller-Hadi C., Martin-Schild S.. ( 2005;). Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. . Clin Infect Dis 41:, e57–e63. [CrossRef][PubMed]
    [Google Scholar]
  3. Beilke M. A., Traina-Dorge V. L., Sirois M., Bhuiyan A., Murphy E. L., Walls J. M., Fagan R., Winsor E. L., Kissinger P. J.. ( 2007;). Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. . Clin Infect Dis 44:, 1229–1234. [CrossRef][PubMed]
    [Google Scholar]
  4. Berger J. R., Raffanti S., Svenningsson A., McCarthy M., Snodgrass S., Resnick L.. ( 1991;). The role of HTLV in HIV-1 neurologic disease. . Neurology 41:, 197–202. [CrossRef][PubMed]
    [Google Scholar]
  5. Cavrois M., Wain-Hobson S., Wattel E.. ( 1995;). Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. . Res Virol 146:, 179–184. [CrossRef][PubMed]
    [Google Scholar]
  6. Cavrois M., Gessain A., Wain-Hobson S., Wattel E.. ( 1996;). Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. . Oncogene 12:, 2419–2423.[PubMed]
    [Google Scholar]
  7. Cavrois M., Leclercq I., Gout O., Gessain A., Wain-Hobson S., Wattel E.. ( 1998;). Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. . Oncogene 17:, 77–82. [CrossRef][PubMed]
    [Google Scholar]
  8. Cavrois M., Gessain A., Gout O., Wain-Hobson S., Wattel E.. ( 2000;). Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. . J Infect Dis 182:, 1044–1050. [CrossRef][PubMed]
    [Google Scholar]
  9. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G.. ( 1985;). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. . Lancet 326:, 407–410. [CrossRef][PubMed]
    [Google Scholar]
  10. Gillet N. A., Malani N., Melamed A., Gormley N., Carter R., Bentley D., Berry C., Bushman F. D., Taylor G. P., Bangham C. R.. ( 2011;). The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. . Blood 117:, 3113–3122. [CrossRef][PubMed]
    [Google Scholar]
  11. Harrison L. H., Vaz B., Taveira D. M., Quinn T. C., Gibbs C. J., de Souza S. H., McArthur J. C., Schechter M.. ( 1997;). Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. . Neurology 48:, 13–18. [CrossRef][PubMed]
    [Google Scholar]
  12. Levin M. C., Lee S. M., Morcos Y., Brady J., Stuart J.. ( 2002;). Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. . J Infect Dis 186:, 1514–1517. [CrossRef][PubMed]
    [Google Scholar]
  13. Machuca A., Rodés B., Soriano V.. ( 2001;). The effect of antiretroviral therapy on HTLV infection. . Virus Res 78:, 93–100. [CrossRef][PubMed]
    [Google Scholar]
  14. Mortreux F., Leclercq I., Gabet A. S., Leroy A., Westhof E., Gessain A., Wain-Hobson S., Wattel E.. ( 2001;). Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. . J Natl Cancer Inst 93:, 367–377. [CrossRef][PubMed]
    [Google Scholar]
  15. Mortreux F., Gabet A. S., Wattel E.. ( 2003;). Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. . Leukemia 17:, 26–38. [CrossRef][PubMed]
    [Google Scholar]
  16. Murphy E. L., Grant R. M., Kropp J., Oliveira A., Lee T. H., Busch M. P.. ( 2003;). Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. . J Acquir Immune Defic Syndr 33:, 655–656. [CrossRef][PubMed]
    [Google Scholar]
  17. Sibon D., Gabet A. S., Zandecki M., Pinatel C., Thête J., Delfau-Larue M. H., Rabaaoui S., Gessain A., Gout O.. & other authors ( 2006;). HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. . J Clin Invest 116:, 974–983. [CrossRef][PubMed]
    [Google Scholar]
  18. Silva M. T., Neves E. S., Grinsztejn B., de Melo Espíndola O., Schor D., Araújo A.. ( 2012;). Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1. . AIDS 26:, 521–523. [CrossRef][PubMed]
    [Google Scholar]
  19. Zane L., Sibon D., Mortreux F., Wattel E.. ( 2009;). Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. . Front Biosci 14:, 3935–3941. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.048348-0
Loading
/content/journal/jgv/10.1099/vir.0.048348-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error